Kobayashi T, Mitsumori K, Kawahara T, Nishizawa K, Ogura K, Ide Y. Prostate cancer detection among men with prostate specific antigen levels of 2.5-4.0 ng/mL in a Japanese urological referral population. J. Urol. 2006; 175: 1281-5....
Prostate-specific antigen levels are increased in men with prostatic disease, including prostate cancer, and have been used clinically to monitor the response of prostate cancer to therapy. More recently, prostate-specific antigen levels, usually in combination with digital rectal examination or transrect...
In this report, we have investigated the relationship between androgen levels and prostate tumorigenesis in Nkx3.1; Pten mutant mice, a genetically engineered mouse model of human prostate cancer. By experimentally manipulating serum levels of testosterone in these mice for an extended period (i.e.,...
Objective The aim of our study was to evaluate the serum levels of CA19-9 in patients with non-small cell lung cancer (NSCLC) and to analyze the relation... X Liu,G Shan,Z Song,... - 中德临床肿瘤学杂志:英文版 被引量: 0发表: 2011年 Prostate cancer with high serum levels of CEA...
Prostate-specific antigen (PSA) levels have been used for detection and surveillance of prostate cancer (PCa). However, factors other than PCa—such as genetics—can impact PSA. Here we present findings from a genome-wide association study (GWAS) of PSA
of prostate cancer, i.e. rs2555019 (it hasr2 = 0.81 with rs127088422) located downstream ofTBX5on 12q24.21, and rs11651052 (which hasr2 = 0.91 with rs443079623) located intronic inHNF1Bon 17q12. Therefore, we performed a GWAS of BPH/LUTS, where we excluded all men known...
These includes the study conducted at the Duke University Medical Center shows that consuming vegetable fats may slow prostate cancer. The study conducted by researchers at the University of Texas Health Science Center San Antonio shows that walnuts can prevent prostate cancer. It mentions that study...
The Prostate Cancer Prevention Trial (PCPT) has challenged the validity of recommended prostate-specific antigen (PSA) thresholds for prostate biopsy (>2.5ng/ml) given the 17% prostate cancer (pCA) detection rate at PSA of 1.1–2.0. The outcome of patients treated at PSA ≤2.5 is poorly defi...
Prostate cancer (PCa) is the second most commonly diagnosed malignant tumor and the fifth leading cause of cancer death in men in the world. The most common types of tumors are adenocarcinomas. Prostate cancer is a slow-growing cancer. The incidence increases with age. Evaluation of proinflammato...
In a log-linear model, both PSA value at baseline (P = .05) and the rate of PSA change (P<.001) were associated with the development of lethal prostate cancer. In the ROC analysis, however, the accuracy of classifying the disease as either indolent or destined to progress was low, ...